FDA Drugs recall ·

Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle ( recall

Recall number
D-0017-2026
Date
(initiated September 19, 2025)
Company / brand
Ascend Laboratories, LLC
135 Us Highway 202 206 Ste 15, Bedminster, NJ, United States
Category
Drugs › Class II
Classification
Class II
Status
Ongoing
Units affected
141,984 bottles
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

Atorvastatin Calcium Tablets USP, 10 mg, Rx Only a) 90-count bottle (NDC 67877-511-90), b). 500-count bottle (NDC 67877-511-05), c). 1000-count bottle (NDC 67877-511-10) Manufactured by: Alkem Laboratories, Ltd. India, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.

Why was it recalled?

Failed Dissolution Specifications

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Lot#: 25141249, Exp. Feb. 2027 Lot#: 24144938, Exp. Nov. 2026 Lot#: 24144868, Exp. Nov. 2026 Lot#: 24144867, Exp. Nov. 2026 Lot#: 24144458, Exp. Sep. 2026 Lot#: 24143994, Exp. Sep. 2026 Lot#: 24142987, Exp. July 2026 Lot#: 24143316, Exp. July 2026

Distribution

U.S. Nationwide

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (drugs), recall D-0017-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.